☰

Akhil Srivastava - Publications

Affiliations: 
University of Hawai'i at Manoa, Honolulu, HI 
Area:
Fungal pathogenesis and genetics
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chinnappan M, Srivastava A, Amreddy N, Razaq M, Pareek V, Ahmed R, Mehta M, Peterson JE, Munshi A, Ramesh R. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs. Cancer Letters. PMID 32439419 DOI: 10.1016/J.Canlet.2020.05.004  0.313
2018 Srivastava A, Amreddy N, Razaq M, Towner R, Zhao YD, Ahmed RA, Munshi A, Ramesh R. Exosomes as Theranostics for Lung Cancer. Advances in Cancer Research. 139: 1-33. PMID 29941101 DOI: 10.1016/Bs.Acr.2018.04.001  0.332
2017 Andrade D, Mehta M, Griffith J, Panneerselvam J, Srivastava A, Kim TD, Janknecht R, Herman T, Ramesh R, Munshi A. YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways. Oncotarget. 8: 98495-98508. PMID 29228705 DOI: 10.18632/Oncotarget.21913  0.307
2017 Amreddy N, Babu A, Panneerselvam J, Srivastava A, Muralidharan R, Chen A, Zhao YD, Munshi A, Ramesh R. Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29155362 DOI: 10.1016/J.Nano.2017.11.010  0.313
2017 Muralidharan R, Babu A, Amreddy N, Srivastava A, Chen A, Zhao YD, Kompella UB, Munshi A, Ramesh R. Tumor-targeted nanoparticle delivery of HuR siRNA inhibits lung tumor growth in vitro and in vivo by disrupting the oncogenic activity of the RNA-binding protein HuR. Molecular Cancer Therapeutics. PMID 28572169 DOI: 10.1158/1535-7163.Mct-17-0134  0.32
2016 Srivastava A, Amreddy N, Babu A, Panneerselvam J, Mehta M, Muralidharan R, Chen A, Zhao YD, Razaq M, Riedinger N, Kim H, Liu S, Wu S, Abdel-Mageed AB, Munshi A, et al. Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells. Scientific Reports. 6: 38541. PMID 27941871 DOI: 10.1038/Srep38541  0.333
2016 Panneerselvam J, Srivastava A, Muralidharan R, Wang Q, Zheng W, Zhao L, Chen A, Zhao YD, Munshi A, Ramesh R. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells. Oncotarget. PMID 27602961 DOI: 10.18632/Oncotarget.11838  0.308
2016 Srivastava A, Babu A, Filant J, Moxley KM, Ruskin R, Dhanasekaran D, Sood AK, McMeekin S, Ramesh R. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. Journal of Biomedical Nanotechnology. 12: 1159-73. PMID 27319211 DOI: 10.1166/Jbn.2016.2205  0.327
2016 Panneerselvam J, Srivastava A, Muralidharan R, Wang Q, Zheng W, Zhao L, Chen A, Zhao Y, Munshi A, Ramesh R. Abstract 3738: IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells Cancer Research. 76: 3738-3738. DOI: 10.1158/1538-7445.Am2016-3738  0.311
2016 Muralidharan R, Amreddy N, Babu A, Srivastava A, Panneerselvam J, Chen A, Zhao YD, Zhao L, Kompella UB, Munshi A, Ramesh R. 489. Tumor-Targeted Hursirna-Nanoparticle Delivery Inhibits Lung Tumor Growth In Vitro and In Vivo Molecular Therapy. 24: S194. DOI: 10.1016/S1525-0016(16)33298-1  0.318
Show low-probability matches.